Cell Therapy

News

Blackstone revs up Autolus' CAR with $250m fuel injection

Private equity firm Blackstone has agreed to provide up to $250 million in financing to UK biotech Autolus Therapeutics, to help it take acute lymphoblastic leukaemia (ALL) CAR-T therapy ob

News

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

Talaris therapy ends need for immune drugs in transplant pat...

Two kidney transplant patients who received a stem cell therapy developed by Talaris Therapeutics were able to come off all immunosuppressant drugs within a year, without any evidence of gr

News

Takeda buys GammaDelta to boost cancer cell therapy credenti...

Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in 'off-the-shelf' cell therapies for solid tumours and blood cancers.

News

FDA halts Allogene CAR-T trial after safety scare

A phase 1 trial of Allogene's of-the-shelf CAR-T for lymphoma has been placed on hold by the FDA, after a "chromosomal abnormality" was seen in a patient receiving the cell therapy.

Events

Partner Content

Next Generation CAR-TCR Summit

Engineering Smarter Adoptive Cell Therapies

News

Young lonely man in a wheelchair on a balcony looking at the nature in the spring

Capricor preps phase 3 for Duchenne cell therapy as it seeks...

Capricor Therapeutics' bid to find a partner for its Duchenne muscular dystrophy (DMD) cell therapy CAP-1002 could get a boost after final phase 2 data showed a strong effect on disease pro

Blackstone revs up Autolus' CAR with $250m fuel injection

Talaris therapy ends need for immune drugs in transplant pat...

Takeda buys GammaDelta to boost cancer cell therapy credenti...

FDA halts Allogene CAR-T trial after safety scare

Next Generation CAR-TCR Summit

Capricor preps phase 3 for Duchenne cell therapy as it seeks...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Cell Therapy

Editor's Picks